Evidence map›Paper›PMID 32576717›Full record

ArticleBiomolecules & therapeutics2020

Diallyl Biphenyl-Type Neolignans Have a Pharmacophore of PPARα/γ Dual Modulators.

Yujia Han, Jingjing Liu, Sungjin Ahn, Seungchan An, Hyejin Ko, Jeayoung C Shin, Sun Hee Jin, Min Won Ki, So Hun Lee, Kang Hyuk Lee and 3 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules & therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Chitobiose exhibited a lipid-lowering effect in ob/obBioresources and bioprocessing · 2023
    Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yujia HanCollege of Pharmacy and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Jingjing LiuCollege of Pharmacy and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Sungjin AhnCollege of Pharmacy and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Seungchan AnCollege of Pharmacy and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Hyejin KoCollege of Pharmacy and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Jeayoung C ShinCollege of Pharmacy and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Sun Hee JinCollege of Pharmacy and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Min Won KiCollege of Pharmacy and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
So Hun LeeSK Bioland, Cheongju 28162, Republic of Korea.
Kang Hyuk LeeSK Bioland, Cheongju 28162, Republic of Korea.
Song Seok ShinSK Bioland, Cheongju 28162, Republic of Korea.
Won Jun ChoiCollege of Pharmacy, Dongguk University, Goyang 10326, Republic of Korea.
Minsoo NohCollege of Pharmacy and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Seoul National University · KRBioland (South Korea) · KRDongguk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adiponectin secretion-promoting compounds have therapeutic potentials in human metabolic diseases. Diallyl biphenyl-type neolignan compounds, magnolol, honokiol, and 4-

Indexed as

AdiponectinDiallyl biphenyl-type neolignansHuman bone marrow mesenchymal stem cellsPeroxisome proliferatoractivated receptor α/γ

Identifiers

PMID32576717
PMCPMC7457167
OpenAlexW3037518248

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.